Commemorative Series No. 2 · The Drug Money
OUTSPENTNo. 16/54
George
Allen
U.S. Senate · R-VA
Taken from pharma & insurers
$72,508
H.R.1 · Medicare drug-price ban · 2003tap to flip ⤺
WHO THEY WORK FORNo. 16/54
Pharma & Health$64,633
Insurers & HMOs$7,875
Banned Medicare from negotiating drug prices for 19 years. Once it could (2024), prices fell 38–79%. · 108-1-459OUTSPENT
Card 16 of 54 · tap the card to see who they work for
Beyond the check
The check is only the part you can see.
They took
$72,508
The industry spent on the bill
$116M
on drug-industry lobbying in 2003, about ten lobbyists for every senator
After office
We checked the public record. No industry job, board seat, or gift after this vote.
Sometimes the vote really is free.
The industry figure is lobbying spent on the bill, not a payment to this senator. Source: Public Citizen (2004); Center for Public Integrity. Everything here is documented public record; nothing alleges an illegal act.
Don't recognize a logo? Here's the key.
Pharma & Health$64,633
Johnson & Johnson$26,183
Bristol Myers Squibb$11,800
Amgen$9,100
Merck$7,800
Pfizer$5,550
Eli Lilly$4,200
Insurers & HMOs$7,875
Aetna$4,750
Cigna$1,250
Humana$1,000
Anthem/Elevance$875